Industry News Roundup
This article was originally published in The Tan Sheet
Executive Summary
NutraClick makes claims probiotic reduces bloating; Nature’s Products adds Nutri-Health brands; DSM invests in ZeaVision; circular inappropriate for e-cigarettes; “robust” evidence need for ME claims; and concussion, drug claims trigger warning letter.
You may also be interested in...
FTC Requests Drug Claim Support For Bayer Probiotic Supplement
On behalf of the FTC, DoJ alleges Bayer violated a 2007 settlement to substantiate supplement claims and asks a court to require the firm to provide two RCTs for dietary supplement claims for Phillips’ Colon Health. Trade groups rally behind the firm, arguing the requirement is unfair and illegal.
In Brief
FDA loses patience with Confidence; Warning underscores interest in concussion claims; Nestle invests in ready-to-drink supplement plant; Garlic supplement makes drug claims; Skin care claims enter drug realm;; more In Brief.
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.